Teva Pharmaceutical Industries Limited provided earnings guidance for the year 2022. The company expects revenue to be in range of $15.6 billion to $16.2 billion, operating income to be in the range of $4.2 billion to $4.5 billion and EPS to be in the range of $2.40 to $2.60.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.6 USD | -0.95% | +1.90% | +59.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.00% | 18.8B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Provides Earnings Guidance for the Year 2022